(Q44025232)

29 November 2017

title

Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1352058

17 September 2022

0 references

I. K. Wright

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1352058

17 September 2022

M. Heaton

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1352058

17 September 2022

N. Upton

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1352058

17 September 2022

C. A. Marsden

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1352058

17 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1352058

17 September 2022

publication date

1 January 1992

1 reference

29 November 2017

number of pages

10

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

29 November 2017

volume

107

1 reference

29 November 2017

issue

2-3

1 reference

29 November 2017

page(s)

405-414

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02245168

29 November 2017

exact match

0 references

cites work

The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist

1 reference

https://api.crossref.org/works/10.1007%2FBF02245168

Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245168

5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245168

The comparative efficacy of buspirone and diazepam in the treatment of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245168

L-5-hydroxytryptophan in the treatment of anxiety disorders

21 January 2018

1 reference

12 December 2020

5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue

1 reference

12 December 2020

Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test

1 reference

12 December 2020

Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist

1 reference

12 December 2020

Serotonin and anxiety revisited

1 reference

12 December 2020

The effect of ketotifen in rodent models of anxiety and on the behavioural consequences of withdrawing from treatment with drugs of abuse.

1 reference

12 December 2020

Effects of idazoxan on dorsal raphe 5-hydroxytryptamine neuronal function

1 reference

12 December 2020

Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects

1 reference

12 December 2020

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

12 December 2020

5-HT1A-sensitive adenylyl cyclase of rodent hippocampal neurons: effects of antidepressant treatments and chronic stimulation with agonists

1 reference

12 December 2020

Exploration of mice in a black and white test box: validation as a model of anxiety.

1 reference

12 December 2020

Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone.

1 reference

12 December 2020

Binding of the putative anxiolytic TVX Q 7821 to hippocampal 5-hydroxytryptamine (5-HT) recognition sites

1 reference

12 December 2020

Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic

1 reference

12 December 2020

The relation between fear induced by novel stimulation and exploratory behavior.

1 reference

12 December 2020

Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors

1 reference

12 December 2020

Alpha-adrenoceptor-mediated modulation of 5-hydroxytryptamine release from rat brain cortex slices

1 reference

12 December 2020

Effect of acute and chronic administration of buspirone on serotonin and benzodiazepine receptor subtypes in the rat brain: an autoradiographic study.

1 reference

12 December 2020

Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821.

1 reference

12 December 2020

An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone

1 reference

12 December 2020

Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain

1 reference

12 December 2020

Modulation of 5-hydroxytryptamine release by presynaptic inhibitory alpha 2-adrenoceptors in the human cerebral cortex

1 reference

12 December 2020

Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ?fear?-motivated behaviour

1 reference

12 December 2020

Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone

1 reference

12 December 2020

Are serotonergic neurons involved in the control of anxiety and in the anxiolytic activity of benzodiazepines?

1 reference

12 December 2020

Neurobiological mechanisms in human anxiety. Evidence supporting central noradrenergic hyperactivity

1 reference

12 December 2020

Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites.

1 reference

12 December 2020

Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists

1 reference

12 December 2020

Catecholamine and 5-HT synthesis ex vivo as an index of in-vivo neuronal activity and regulation

1 reference

12 December 2020

Lack of effects of 5HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat.

1 reference

12 December 2020

Regulation of noradrenaline release by presynaptic receptor systems

1 reference

12 December 2020

Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse.

1 reference

12 December 2020

Pharmacological and clinical effects of buspirone

1 reference

12 December 2020

The alpha 2-adrenoceptor antagonist activity of ipsapirone and gepirone is mediated by their common metabolite 1-(2-pyrimidinyl)-piperazine (PmP)

1 reference

12 December 2020

The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam

1 reference

12 December 2020

One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02245168

1 reference

29 November 2017

1 reference